Biotech investors spent years waiting for the sector to recover from its brutal 2021 peak. That patience is finally paying ...

Biotech stocks have rallied strongly into 2026, building on the late-2025 momentum from positive clinical data, cheaper valuation, easy money policy and favorable macro conditions. Biotech-based ...

A run-up in biotech and drug stocks that sent valuations soaring through the second half of 2025 was looking a bit shaky on ...

The tech sector has been far choppier in recent weeks, and the new year might see more of the same as volatility continues working its way through parts of the tech scene. Notably, the software stocks ...

Cathie Wood's ARK bought $13.7M Roblox stock and sold $12.7M Meta stock Jan 6, 2026. Full breakdown of ARK ETF trades and ...

Following closely was a substantial buy of 262,769 shares of Personalis Inc (NASDAQ:PSNL) through the ARKG ETF, totaling $2,200,690. This marks an ongoing trend of accumulation in Personalis, as ARK ...

Most vanilla investors limit their retirement income ideas to the exchange-traded funds (ETFs) advertised on TV. Don’t do it!

What Changed in the Invivyd Price Target The latest update keeps Invivyd’s fair value anchor at 10.0, but the supporting ...

Looking back at the performance of ARK Invest, led by Cathie Wood (“Cathie Wood”), in 2025, despite reducing its holdings of Tesla (TSLA) by over 633,000 shares during the ...

A successful Phase 3 trial and a public offeringof stock boosted prospects for this company to receive approval for an ...